Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734273 · ClinicalTrials.gov registry record · Early Phase 1
Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss
A Early Phase 1 study of Obesity and Obesity-related Medical Conditions, sponsored by Nicholas Skertich.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT06734273: Recruiting Early Phase 1 study of Obesity and Obesity-related Medical Conditions, sponsored by Nicholas Skertich.
NCT06734273 is a Early Phase 1 study of Obesity and Obesity-related Medical Conditions that is actively recruiting participants, run by Nicholas Skertich. The registered enrollment target is 42 participants, below the 534-participant average among 13 other Obesity and Obesity-related Medical Conditions trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06734273, a Early Phase 1 study of Obesity and Obesity-related Medical Conditions, is actively recruiting participants, sponsored by Nicholas Skertich.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.
Conditions Studied
Interventions
- PROCEDURE Sleeve Gastrectomy
- DRUG Mounjaro
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2028-03 |
| Phase | Early Phase 1 |
What NCT06734273 shows while recruiting
NCT06734273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 534-participant average among 13 other Obesity and Obesity-related Medical Conditions trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Obesity and Obesity-related Medical Conditions appearing as the primary indexed condition, and to 2 interventions - of which Sleeve Gastrectomy is the first listed.
NCT06734273 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06734273 about?
NCT06734273 is a clinical study titled "Randomized Control Trial of Sleeve Gastrectomy with Tirzepatide in Maximizing Weight Loss". This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; wheth...
What is the current status of trial NCT06734273?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2025-03-10. Estimated completion is 2028-03.
What conditions does trial NCT06734273 study?
This clinical trial studies the following conditions: Obesity and Obesity-related Medical Conditions.
What interventions are being tested in trial NCT06734273?
The interventions under investigation include: Sleeve Gastrectomy (PROCEDURE), Mounjaro (DRUG).
Who is sponsoring clinical trial NCT06734273?
This trial is sponsored by Nicholas Skertich, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06734273 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Obesity-related Medical Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06734273's enrollment target sits among peer trials
42 10th of 13 higher than 4 of 13 other Obesity and Obesity-related Medical Conditions trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity and Obesity-related Medical Conditions trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
RECRUITING
-
New Mechanisms of Obesity
RECRUITING · NA
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
RECRUITING · NA
-
REvision of VSG with Ablation of the Mucosa Procedure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI